Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
Clinical trial NCT02945150 · COMPLETED
Trial details
- NCT number
- NCT02945150
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2019-08-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.